Please login to the form below

Not currently logged in
Email:
Password:

dry eye

This page shows the latest dry eye news and features for those working in and with pharma, biotech and healthcare.

Pharma Brand Planners' Blog (Part 5)

Pharma Brand Planners' Blog (Part 5)

t leave a dry eye in the room to a global launch plan presentation from the US brand lead that made the audience laugh, cheer and shout with enthusiasm.

Latest news

More from news
Approximately 4 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    RNA‐targeted therapeutic, IONIS‐FB‐LRx targeting Factor. B, for Geographic Atrophy, an advanced form of dry Age-related Macular Degeneration (AMD). ... According to Bloomberg, the products Xiidra eyedrops for dry eye and Natpara for

  • The good, the bad and the ugly The good, the bad and the ugly

    Bayer’s growth - a healthy 14.6% - was stimulated by a steady performance by Xarelto in Europe and Asia, and strong sales of its eye medicine Eylea in Japan, Europe and ... In second position, Allergan experienced modest sales growth of 2.3%.

  • Pharma deals in July 2015 Pharma deals in July 2015

    The third deal by Allergan to bolster its pipeline was the acquisition of Occuleve, a medical device company with a product in late stage development for treating dry eyes. ... Company acquisition. Dry eye device. 125+. Novartis / Mereo. Divestment of

  • Pharma deals during March 2013 Pharma deals during March 2013

    However, ophthalmology is increasingly an area of interest in the industry with potential for growth as the global population ages; it is estimated that around 25m people have dry eye disease ... 175. SARcode Bioscience/ Shire. Acquisition. SAR 1118 for

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    Novartis focuses on high-growth areas in healthcare, spanning innovative pharmaceuticals, eye care, generics, consumer health, plus vaccines and diagnostics. ... R&D focus is on discovering new treatments for conditions including age-related macular

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics